U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. has formally launched a program aimed at helping Americans reduce their use of antidepressant medications. This initiative is a core component of his Make America Healthy Again (MAHA) agenda.

According to The New York Times, Kennedy has long criticized Americans’ overreliance on psychiatric medications, particularly the widespread use of selective serotonin reuptake inhibitors (SSRIs) and other antidepressants. His new policies aim to change current prescription patterns.

Kennedy’s position is rooted in skepticism about the current mental health treatment system. He argues that pharmaceutical interventions are over-relied upon, while non-pharmacological approaches such as lifestyle changes, psychotherapy, and nutritional interventions are overlooked.

However, this plan has faced strong pushback from the medical community. Multiple psychiatrists and medical researchers have pointed out that antidepressant medications are necessary treatments for patients with clinical depression, and reducing prescriptions could deprive millions of patients of effective treatment.

The American Psychiatric Association has previously issued a statement indicating that the use of antidepressant medications should be based on evidence-based medical principles, with professional doctors making judgments based on individual patient circumstances, rather than being uniformly restricted by government-level policies.

Data shows that approximately 15% of American adults are currently using some form of antidepressant medication, a proportion that has steadily risen over the past two decades. Critics argue this growth reflects increased mental health issues and improved diagnosis rates, rather than medication overuse.

Kennedy’s MAHA agenda has previously proposed several controversial policy recommendations, including strict definitions and restrictions on ultra-processed foods. This push against antidepressants further highlights the tension between his natural therapy inclinations and mainstream medicine.

Source: The New York Times